Scientists identify novel target for heart failure therapyMarch 17th, 2009 - 12:40 pm ICT by ANI
Washington, Mar 17 (ANI): Researchers from Thomas Jefferson University have identified a novel signalling pathway that can be a potential target for heart failure therapy.
The pathway plays a significant role in the production of aldosterone, a hormone that promotes heart failure after a myocardial infarction.
Aldosterone production is mediated by a protein called beta-arrestin-1. Aldosterone is secreted by the adrenal cortex and its levels are elevated in chronic heart failure.
Its presence contributes to morbidity and mortality of the disease.
According to Anastasios Lymperopoulos, Ph.D., the production of aldosterone was previously thought to be solely the result of the activation of G-proteins.
“The bottom line is that in order to effectively suppress aldosterone production, you need to inhibit beta-arrestin-1 in addition to inhibiting G-proteins,” said Lymperopoulos.
Walter Koch, Ph.D., the W.W. Smith Professor of Medicine and the Director of the Center for Translational Medicine and the George Zallie and Family Laboratory for Cardiovascular Gene Therapy, said that the findings clearly indicate beta-arrestin1 plays a more significant role in aldosterone secretion than G-proteins.
“Aldosterone secretion is dependent on beta-arrestin-1,” Dr. Koch said.
“It may not be independent of G-proteins, but beta-arrestin-1 is definitely the critical player.
The goal should be to find a new antagonist that can block beta-arrestin-1 and G-protein activation equally well. Doing so would lead to lower aldosterone levels at its source and alleviate negative remodelling processes in the injured heart,” he added.
The study appears in Proceedings of the National Academy of Sciences. (ANI)
- Gene therapy effectively reverses heart damage - Dec 30, 2008
- Molecule involved in heart failure 'also leads to heat attack damage' - Sep 16, 2010
- Blocking action of protein blunts serious ill effects of high BP on heart - May 03, 2011
- Scientists identify new longevity protein - May 08, 2010
- New protein involved in longevity identified - May 08, 2010
- Protein pathway find may help solve Parkinson's disease - Mar 01, 2011
- Adrenalin may help combat heart attack - Jun 25, 2010
- Brain protein shows promise in checking obesity - Aug 10, 2011
- Exercise protects heart from injury through nitric oxide - May 05, 2011
- Study offers potential new targets for novel anti-HIV drugs - Mar 26, 2011
- Kidney gene linked to increased heart failure risk - Jan 18, 2011
- New hope for heart patients - Jul 21, 2011
- Scientists clue in on why saliva glands stop working - Jun 03, 2011
- New therapeutic target for Alzheimer's identified - Sep 22, 2010
- New path discovered for colon cancer drug discovery - Nov 20, 2010
Tags: adrenal cortex, aldosterone levels, aldosterone secretion, anastasios, chronic heart failure, critical player, dr koch, g proteins, gene therapy, heart failure, heart failure therapy, morbidity and mortality, myocardial infarction, national academy of sciences, proceedings of the national academy, proceedings of the national academy of sciences, smith professor, target, thomas jefferson university, walter koch